Literature DB >> 28573818

The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.

Sula Windgassen1, Rona Moss-Morris2, Joseph Chilcot2, Alice Sibelli2, Kimberley Goldsmith3, Trudie Chalder1,4.   

Abstract

PURPOSE: Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder characterized by abdominal pain and altered bowel habits. It is estimated to affect 10-22% of the UK population. The use of psychological interventions in IBS is increasingly empirically supported, but little is known about the mechanism of psychological treatment approaches. The present systematic review aimed to investigate the mechanisms of psychological treatment approaches applied to IBS.
METHODS: The systematic review included studies conducting mediation analysis in the context of psychological interventions for IBS, focusing on the outcomes of symptom severity and/or quality of life (QoL).
RESULTS: Nine studies in total were included in the review. Eight of the studies assessed mediation in the context of cognitive behavioural-based interventions, and one study assessed mediation in a mindfulness-based stress reduction intervention. Results indicate that change in illness-specific cognitions is a key process by which psychological treatments may have an effect on the outcomes of symptom severity and QoL. Furthermore, results suggest that whilst GI-specific anxiety may also be a key mechanism of treatment effect, it would appear that general or state anxiety is not. Although less commonly included in mediation analysis, illness-specific behaviours may also have a mediating role.
CONCLUSIONS: A mediational model amalgamating the results of studies is proposed to illustrate the findings of the review. The model depicts the process by which psychotherapy changes illness-specific cognitions, behaviours, and anxiety to achieve reduction in symptom severity. Statement of contribution What is already known on this subject? Cognitive behavioural therapy (CBT) is the predominant psychological treatment for irritable bowel syndrome (IBS), although there is some research supporting other treatments such as mindfulness and hypnotherapy. Mediation analysis in the context of psychological treatments for IBS has just begun to explore possible mechanisms of treatment effect especially within CBT studies. Some studies include anxiety in a basic mediation analysis, whilst others include cognitions with inconsistent results for each. What does this study add? Reviews mediators included in mediation analysis and the methods used for mediation analysis Proposes a mediation model informed by the results of the review for future studies to investigate Provides clinical implications for the targeting of cognitions and behaviours rather than general anxiety.
© 2017 The British Psychological Society.

Entities:  

Keywords:  anxiety; cognitions; cognitive behavioural therapy; gastroinstestinal specific anxiety; illness-related behaviours; irritable bowel syndrome; mechanisms; mediation analysis; systematic review

Mesh:

Year:  2017        PMID: 28573818     DOI: 10.1111/bjhp.12250

Source DB:  PubMed          Journal:  Br J Health Psychol        ISSN: 1359-107X


  14 in total

1.  Spiritual Care within Dietetic Practice: A Systematic Literature Review.

Authors:  Deborah Lycett; Riya Patel
Journal:  J Relig Health       Date:  2022-04-29

2.  Compensatory bladder behaviors ("coping") in women with overactive bladder.

Authors:  William Stuart Reynolds; Melissa R Kaufman; Stephen Bruehl; Roger R Dmochowski; Lindsey C McKernan
Journal:  Neurourol Urodyn       Date:  2021-09-15       Impact factor: 2.367

3.  A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.

Authors:  Kendra J Kamp; Anna M Plantinga; Kevin C Cain; Robert L Burr; Pamela Barney; Monica Jarrett; Ruth Ann Luna; Tor Savidge; Robert Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2021-01-08       Impact factor: 2.318

4.  The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.

Authors:  Xin Yao; Yunsheng Yang; Shutian Zhang; Yu Shi; Qian Zhang; Yongjun Wang
Journal:  BMC Gastroenterol       Date:  2020-07-06       Impact factor: 3.067

Review 5.  Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials.

Authors:  Amanda C Fifi; Cara Hannah Axelrod; Partha Chakraborty; Miguel Saps
Journal:  Nutrients       Date:  2018-11-09       Impact factor: 5.717

6.  Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial.

Authors:  Hugo Wallén; Perjohan Lindfors; Erik Andersson; Erik Hedman-Lagerlöf; Hugo Hesser; Nils Lindefors; Cecilia Svanborg; Brjánn Ljótsson
Journal:  BMC Gastroenterol       Date:  2021-07-13       Impact factor: 3.067

7.  Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.

Authors:  Jeffrey M Lackner; James Jaccard
Journal:  J Consult Clin Psychol       Date:  2021-05

8.  The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome.

Authors:  Ryo Katsumata; Akiko Shiotani; Takahisa Murao; Manabu Ishii; Minoru Fujita; Hiroshi Matsumoto; Ken Haruma
Journal:  J Clin Biochem Nutr       Date:  2018-01-27       Impact factor: 3.114

Review 9.  Treating irritable bowel syndrome through an interdisciplinary approach.

Authors:  Dominika Dorota Nelkowska
Journal:  Ann Gastroenterol       Date:  2019-11-29

10.  A Coached Digital Cognitive Behavioral Intervention Reduces Anxiety and Depression in Adults With Functional Gastrointestinal Disorders.

Authors:  Eva Szigethy; Aylin Tansel; Alexa N Pavlick; Maria A Marroquin; Catherine D Serio; Valerie Silfee; Meredith L Wallace; Michael J Kingsley; David J Levinthal
Journal:  Clin Transl Gastroenterol       Date:  2021-12-07       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.